Cytarabine/Daunorubicin/Gemtuzumab Ozogamicin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of cytarabine, daunorubicn, and gemtuzumab ozogamicin that can be used for the treatment of acute myeloid leukemia (AML). Intermediate-dose cytarabine/daunorubicin/gemtuzumab ozogamicin regimen may be used for the treatment of AML.

**Synonyms:** - Cytarabine Plus Daunorubicin Plus Gemtuzumab Ozogamicin - Cytarabine, Daunorubicin, Gemtuzumab ozogamicin - Cytarabine-Daunorubicin-Gemtuzumab Ozogamicin - Cytarabine-Daunorubicin-Gemtuzumab Ozogamicin Regimen - Cytarabine/Daunorubicin/Gemtuzumab Ozogamicin - Cytarabine/Daunorubicin/Mylotarg